In addition, alleviating pro-lipogenic, pro-inflammatory, and the oxidative stress induced by HFD is an important way to resist NAFLD, including modulation the activity of the transcription factors PPAR-alpha, SREBP-1c, Nrf2, and NF-κB [48–50]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.